Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share (DRMA) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2024 to Q3 2025

Type / Class
Equity / Common stock, par value $0.0001 per share
Symbol
DRMA on Nasdaq
Shares outstanding
2,673,800
Price per share
$0.70
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
0
Total reported value
$0
Share change
-508,154
Value change
-$297,499
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share (DRMA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 10% 0% $862,712 +$638,810 1,065,076 +285% Armistice Capital, LLC 31 Mar 2025
PROEHL GERALD T 13% $651,319 804,098 PROEHL GERALD T 27 Mar 2025
INTRACOASTAL CAPITAL, LLC 5.5% $102,941 +$86,603 147,059 +530% Mitchell P. Kopin 24 Dec 2025

As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share (DRMA). This represents 0% of the company’s total 2,673,800 outstanding shares.

Institutional Holders of Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share (DRMA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$297,499 $0.70 0
2025 Q2 508,154 $297,499 -$7,049 $0.58 10
2025 Q1 518,513 $561,194 +$512,021 $1.08 8
2024 Q4 45,529 $61,465 +$51,415 $1.35 6
2024 Q3 6,444 $10,568 -$65,071 $1.64 4
2024 Q2 32,770 $78,254 +$78,254 $2.39 6